Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Encysive raises $15 million

ENCY raised $15 million in a registered direct offering of 7.7

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE